Long term data were announced from a phase 3 trial evaluating baricitinib in adolescents aged 12 to less than 18 years with severe alopecia areata.

The overall incidence of psoriasis has nearly doubled globally over 3 decades, with further significant increases predicted by 2040.

The stillbirth rate among singleton births in the United States from 2016 through 2022 was 6.8 per 1000 births.

Therapeutic plasma exchange may allow patients with advanced melanoma to overcome immune checkpoint inhibitor resistance, data suggest.

Developers of biosimilars will no longer be required by the FDA to conduct clinical trials to prove effectiveness.

The risk for persistent opioid prescriptions in offspring was doubled if a mother or father had 2 or more opioid prescriptions.

Children experiencing the psychological stress of 'new family structure' in first year of life have increased psoriasis risk.